Isavuconazonium
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 124 publications
Navigating Therapeutic drug monitoring of Isavuconazole in Invasive Mold Infection on Extracorporeal membrane oxygenation - A Case Report.
Journal: Innovations in pharmacy
Published: June 08, 2026
Early adjunct anti-PD-L1 immunotherapy improves outcomes and restores infection-induced immune paralysis in mice with invasive pulmonary mucormycosis.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 20, 2026
Successful Long-Term Use of Isavuconazole in a Tacrolimus-Treated Japanese Kidney Transplant Recipient With Disseminated Cryptococcosis and Probable Invasive Aspergillosis.
Journal: Cureus
Published: February 12, 2026
The Activity of FDA-Approved Prodrug Isavuconazonium Sulfate and Its Major Metabolite Isavuconazole Against Naegleria fowleri.
Journal: Pharmaceutics
Published: September 29, 2025
Pharmacokinetic Interaction Between Isavuconazole and Rifabutin in a Real-World Setting.
Journal: Mycoses
Published: August 15, 2025
Graded isavuconazonium sulfate challenge in a patient with hypersensitivity to fluconazole.
Journal: IDCases
Published: July 29, 2025
Early adjunct anti-PD-L1 immunotherapy improves outcomes and restores infection-induced immune paralysis in mice with invasive pulmonary mucormycosis.
Journal: bioRxiv : the preprint server for biology
Published: July 14, 2025
A human-relevant alternative infection model for mucormycosis using the silkworm Bombyx mori.
Journal: PloS one
Published: May 13, 2025
The Effect of Drug-Drug Interactions on the Pharmacokinetics of Isavuconazole: A Comprehensive Review.
Journal: Clinical pharmacology : advances and applications
Published: March 25, 2025
Last Updated: 06/30/2026